Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 12974-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#12974-1-AP, RRID:AB_2078510
- Product name
- CDC5L antibody
- Antibody type
- Polyclonal
- Description
- CDC5L antibody (Cat. #12974-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IF, IP, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references LncRNA AC098613.1 promotes acute myeloid leukemia cell differentiation through CDC5L/ADAP1/NRD1 axis.
CDC5L facilitates cardiomyocyte proliferation and ameliorates myocardial ischemia-reperfusion injury via modulation of the FGF10-YAP axis.
CDC5L binds to ELAVL1 to inhibit pyroptosis in hepatocellular carcinoma through the Caspase 3/GSDME signaling pathway.
Circ-PGAM1 promotes malignant progression of epithelial ovarian cancer through regulation of the miR-542-3p/CDC5L/PEAK1 pathway.
O-GlcNAcylation of Thr(12)/Ser(56) in short-form O-GlcNAc transferase (sOGT) regulates its substrate selectivity.
CDC5L drives FAH expression to promote metabolic reprogramming in melanoma.
Jiang Q, Wang X, Yao H, Wang J, Tang P, Liang M, Pan Z, Li B, Lin C, Wu Q, Wang Q, Zheng Q, Kuok CF, Liu H, Sun C, Li D
Apoptosis : an international journal on programmed cell death 2026 Feb 9;31(2):67
Apoptosis : an international journal on programmed cell death 2026 Feb 9;31(2):67
CDC5L facilitates cardiomyocyte proliferation and ameliorates myocardial ischemia-reperfusion injury via modulation of the FGF10-YAP axis.
Wei T, Wan T, Sun Y, Liang Y, Lin Z, Shen S, Zhang Q, Chen M, Li Y
Acta biochimica et biophysica Sinica 2025 Nov 14;57(12):2110-23
Acta biochimica et biophysica Sinica 2025 Nov 14;57(12):2110-23
CDC5L binds to ELAVL1 to inhibit pyroptosis in hepatocellular carcinoma through the Caspase 3/GSDME signaling pathway.
Liang S, Zhu Z, Tang Y, Zhou S, Xiao M, Gong X, Ye K
International journal of molecular medicine 2025 Dec;56(6)
International journal of molecular medicine 2025 Dec;56(6)
Circ-PGAM1 promotes malignant progression of epithelial ovarian cancer through regulation of the miR-542-3p/CDC5L/PEAK1 pathway.
Zhang C, Li Y, Zhao W, Liu G, Yang Q
Cancer medicine 2020 May;9(10):3500-3521
Cancer medicine 2020 May;9(10):3500-3521
O-GlcNAcylation of Thr(12)/Ser(56) in short-form O-GlcNAc transferase (sOGT) regulates its substrate selectivity.
Liu L, Li L, Ma C, Shi Y, Liu C, Xiao Z, Zhang Y, Tian F, Gao Y, Zhang J, Ying W, Wang PG, Zhang L
The Journal of biological chemistry 2019 Nov 8;294(45):16620-16633
The Journal of biological chemistry 2019 Nov 8;294(45):16620-16633
CDC5L drives FAH expression to promote metabolic reprogramming in melanoma.
Gu Z, Zhang H, Li Y, Shen S, Yin X, Zhang W, Cheng R, Zhang Y, Zhang X, Chen H, Huang B, Cao Y
Oncotarget 2017 Dec 26;8(69):114328-114343
Oncotarget 2017 Dec 26;8(69):114328-114343
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The CDC5L antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human CDC5L. This antibody recognizes human, mouse, rat antigen. The CDC5L antibody has been validated for the following applications: ELISA, WB analysis.
